PT Murni Sadar Tbk (MTMH.JK)
IDR 980.0
(-2.49%)
IDR 980.0
(-2.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 921.91 Billion IDR | 12.12% |
| 2022 | 822.28 Billion IDR | -16.36% |
| 2021 | 983.16 Billion IDR | 72.86% |
| 2020 | 568.77 Billion IDR | 28.21% |
| 2019 | 443.64 Billion IDR | 30.21% |
| 2018 | 340.72 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 281.64 Billion IDR | 7.5% |
| 2024 Q2 | 261.99 Billion IDR | -0.63% |
| 2024 Q1 | 263.65 Billion IDR | 8.46% |
| 2023 Q2 | 207.51 Billion IDR | -6.28% |
| 2023 Q3 | 249.9 Billion IDR | 20.43% |
| 2023 Q4 | 243.07 Billion IDR | -2.73% |
| 2023 Q1 | 221.42 Billion IDR | -0.79% |
| 2023 FY | 921.91 Billion IDR | 12.12% |
| 2022 FY | 822.28 Billion IDR | -16.36% |
| 2022 Q4 | 223.19 Billion IDR | 11.46% |
| 2022 Q2 | 179.62 Billion IDR | -18.07% |
| 2022 Q1 | 219.22 Billion IDR | 11.42% |
| 2022 Q3 | 200.24 Billion IDR | 11.48% |
| 2021 Q1 | 268.33 Billion IDR | 0.0% |
| 2021 Q3 | 249.73 Billion IDR | -6.93% |
| 2021 Q2 | 268.33 Billion IDR | 0.0% |
| 2021 FY | 983.16 Billion IDR | 72.86% |
| 2021 Q4 | 196.76 Billion IDR | -21.21% |
| 2020 FY | 568.77 Billion IDR | 28.21% |
| 2019 FY | 443.64 Billion IDR | 30.21% |
| 2018 FY | 340.72 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Bundamedik Tbk | 1488.19 Billion IDR | 38.052% |
| PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -279.887% |
| PT Medikaloka Hermina Tbk | 5784.08 Billion IDR | 84.061% |
| PT Mitra Keluarga Karyasehat Tbk | 4264.27 Billion IDR | 78.381% |
| PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | 49.875% |
| PT Royal Prima Tbk | 265.33 Billion IDR | -247.45% |
| PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | -146.897% |
| PT Sarana Meditama Metropolitan Tbk | 1535.63 Billion IDR | 39.965% |
| PT Siloam International Hospitals Tbk | 11190.51 Billion IDR | 91.762% |
| PT Sejahteraraya Anugrahjaya Tbk | 2503.17 Billion IDR | 63.17% |